| Identification | Back Directory | [Name]
N-heptadecanoyl-D-erythro-sphingosylphosphorylcholine | [CAS]
121999-64-2 | [Synonyms]
17:0 SM (d18:1/17:0)
C17 Sphingomyelin (d18:1/17:0)
N-heptadecanoyl-D-erythro-sphingosylphosphorylcholine
N-HEPTADECANOYL-D-ERYTHRO-SPHINGOSYLPHOSPHORYLCHOLINE;17:0 SM (D18:1/17:0) | [Molecular Formula]
C40H81N2O6P | [MDL Number]
MFCD08703041 | [MOL File]
121999-64-2.mol | [Molecular Weight]
717.07 |
| Hazard Information | Back Directory | [Description]
C17 Sphingomyelin is a synthetic derivative of sphingomyelin that has been used as an internal standard for the quantification of sphingomyelin.1,2 | [Uses]
C17 Sphingomyelin is a synthetic derivative of sphingomyelin that has been used as an internal standard for the quantification of sphingomyelin. | [Definition]
ChEBI: N-heptadecanoylsphingosine-1-phosphocholine is a sphingomyelin d18:1 in which the acyl group specified is heptadecanoyl. It has a role as a mouse metabolite. It is a sphingomyelin d18:1 and a sphingomyelin 35:1. It is functionally related to a heptadecanoic acid. | [storage]
Store at -20°C | [References]
1. Yang, Y., Kuwano, T., Lagor, W.R., et al. Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid species Lipids 49(6),505-515(2014).
2. St?hlman, M., Fagerberg, B., Adiels, M., et al. Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: Impact on small HDL particles Biochim. Biophys. Acta 1831(11),1609-1617(2013). |
|
| Company Name: |
Enzo Biochem Inc
|
| Tel: |
Enzo Biochem Inc. 13797054060 |
| Website: |
www.enzo.com |
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|